bromodeoxyuridine has been researched along with Lymphatic Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, X; Gao, JX; Godfrey, VL; Jiang, Q; Liu, Y; Seifers, N; Su, L; Wen, J; Zheng, P; Zuo, T | 1 |
| Bordigoni, P; Chery, M; Gilgenkrantz, S; Gregoire, MJ; Olive, D | 1 |
2 other study(ies) available for bromodeoxyuridine and Lymphatic Diseases
| Article | Year |
|---|---|
The Scurfy mutation of FoxP3 in the thymus stroma leads to defective thymopoiesis.
Topics: Animals; Apoptosis; Autoimmune Diseases; Bromodeoxyuridine; DNA Primers; Flow Cytometry; Forkhead Transcription Factors; Luciferases; Lymphatic Diseases; Mice; Mice, Inbred BALB C; Mutation; Reverse Transcriptase Polymerase Chain Reaction; Stromal Cells; Thymus Gland | 2005 |
[Fragile site on chromosome 2 (q11) in a case of familial lymphohistiocytosis].
Topics: 4-Nitroquinoline-1-oxide; Adult; Bromodeoxyuridine; Cells, Cultured; Chromosome Fragile Sites; Chromosome Fragility; Chromosomes, Human, 1-3; Distamycins; Female; Humans; Infant; Interferon Type I; Karyotyping; Lymphatic Diseases; Lymphocytes; Lymphocytosis; Male; Methyl Methanesulfonate | 1984 |